Therapeutic Asset Ratings

131 results matching 1 filter

133,990 assets · 8,802 sponsors · 3,128 indications

Methodology v0.2

Asset	Sponsor	Phase	Rating
Aln-Pnp Healthy Volunteers	Regeneron Pharmaceuticals	P1/2	CC (45)
Nelitolimod Breast Cancer	QuantumLeap Healthcare Collaborative	P2	CC (44)
Nelitolimod Locally Advanced Pancreatic Adenocarcinoma	TriSalus Life Sciences, Inc.	P1	CC (44)
Nelitolimod Hepatocellular Carcinoma	University of California, San Diego	P1/2	CC (44)
Vidutolimod Triple Negative Breast Cancer	Regeneron Pharmaceuticals	P2	CC (43)
bp1001-a Carcinoma, Ovarian Epithelial	Bio-Path Holdings, Inc.	P1	CC (43)
bp1002; liposomal bcl-2 antisense oligodeoxynucleotide Acute Myeloid Leukemia, in Relapse	Bio-Path Holdings, Inc.	P1	CC (43)
Cdk-004 Colorectal Cancer Metastatic to Liver	Codiak BioSciences	P1	CC (43)
Cdk-004 Gastric Cancer Metastatic to Liver	Codiak BioSciences	P1	CC (43)
DNA, D(3'-AMINO-3'-DEOXY-P-THIO)(T-A-G-G-G-T-T-A-G-A-C-A-A), 5'-(O-(2-HYDROXY-3-((1-OXOHEXADECYL)AMINO)PROPYL) HYDROGEN PHOSPHOROTHIOATE) Recurrent Childhood Myelodysplastic Syndrome	Children's Oncology Group	P1	CC (43)
DNA, D(3'-AMINO-3'-DEOXY-P-THIO)(T-A-G-G-G-T-T-A-G-A-C-A-A), 5'-(O-(2-HYDROXY-3-((1-OXOHEXADECYL)AMINO)PROPYL) HYDROGEN PHOSPHOROTHIOATE) Recurrent Juvenile Myelomonocytic Leukemia	Children's Oncology Group	P1	CC (43)
DNA, D(3'-AMINO-3'-DEOXY-P-THIO)(T-A-G-G-G-T-T-A-G-A-C-A-A), 5'-(O-(2-HYDROXY-3-((1-OXOHEXADECYL)AMINO)PROPYL) HYDROGEN PHOSPHOROTHIOATE) Relapsed Acute Myeloid Leukemia	Douglas Tremblay	P1	CC (43)
DNA, D(P-THIO)(T-G-A-C-T-G-T-G-A-A-C-G-T-T-C-G-A-G-A-T-G-A) UNCOSASODIUM Recurrent Epithelial Ovarian Cancer Which Includes Epithelial Ovarian, Fallopian Tube and/or Primary Peritoneal Cancer	PhotonPharma, Inc.	P1	CC (43)
Elebsiran Hepatic Impairment	Vir Biotechnology, Inc.	P1	CC (43)
Human Single Chain Il-12 Mrna-Multiple Dose Patients With Advanced Solid Tumors	Cancer Institute and Hospital, Chinese Academy of Medical Sciences	P1	CC (43)
Mir-126 Inhibitor Miristen Recurrent Acute Myeloid Leukemia	City of Hope Medical Center	P1	CC (43)
Mivelsiran Early-Onset Alzheimer Disease	Alnylam Pharmaceuticals	P1	CC (43)
Ncp-Cd47 Sirna Intratumorally Metastases	West China Hospital	P1	CC (43)
Nl-Chchd-001 Amyotrophic Lateral Sclerosis	n-Lorem Foundation	P1/2	CC (43)
bp1001-a Fallopian Tube Neoplasms	Bio-Path Holdings, Inc.	P1	CC (41)
bp1001-a Peritoneal Cancer	Bio-Path Holdings, Inc.	P1	CC (41)
Cdk-004 Advanced Hepatocellular Carcinoma (HCC)	Codiak BioSciences	P1	CC (41)
DNA, D(3'-AMINO-3'-DEOXY-P-THIO)(T-A-G-G-G-T-T-A-G-A-C-A-A), 5'-(O-(2-HYDROXY-3-((1-OXOHEXADECYL)AMINO)PROPYL) HYDROGEN PHOSPHOROTHIOATE) Recurrent Childhood Acute Myeloid Leukemia	Children's Oncology Group	P1	CC (41)
Epha2-Targeting Dopc-Encapsulated Sirna Advanced Malignant Solid Neoplasm	M.D. Anderson Cancer Center	P1	CC (41)
Cd-Ga-102 Advanced Hepatocellular Carcinoma	Shanghai Changzheng Hospital	Early P1	CC (41)

Showing 76 to 100 of 131 assets

PreviousPage 4 of 6Next